LPL Financial
NUVB icon

LPL Financial’s Nuvation Bio NUVB Stock Holding History

LPL Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.9K Sell
12,653
-38,487
-75% -$188K ﹤0.01% 5977
2026
Q1 		$219K Buy
51,140
+10,168
+25% +$56.6K ﹤0.01% 5433
2025
Q4 		$367K Sell
40,972
-35,999
-47% -$223K ﹤0.01% 4989
2025
Q3 		$285K Buy
76,971
+42,741
+125% +$116K ﹤0.01% 5086
2025
Q2 		$66.7K Buy
34,230
+1,382
+4% +$2.88K ﹤0.01% 5329
2025
Q1 		$57.8K Buy
32,848
+1,500
+5% +$3.41K ﹤0.01% 5138
2024
Q4 		$83.4K Buy
31,348
+6,673
+27% +$17.2K ﹤0.01% 5023
2024
Q3 		$56.5K Buy
+24,675
New +$75.3K ﹤0.01% 4983

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

LPL Financial's NUVB Position: Q2 2026 in Review

LPL Financial reduced its Nuvation Bio (NUVB) stake by 75% in Q2 2026, selling an estimated $188K and leaving 12,653 shares worth $71.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5977.

LPL Financial first reported a position in NUVB in Q3 2024 and has held it in 8 quarters since. The position peaked at $367K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • LPL Financial held 12,653 shares of Nuvation Bio worth $71.9K as of Q2 2026.
  • LPL Financial sold 38,487 Nuvation Bio shares in Q2 2026, an estimated $188K.
  • Nuvation Bio made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5977 holding.
  • LPL Financial first reported a position in Nuvation Bio in Q3 2024 and has held it in 8 quarters since.
  • LPL Financial's Nuvation Bio position peaked at $367K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.